Groupama Asset Management’s Elevance Health ELV Stock Holding History

Groupama Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.44M	Buy	8,892 +135	+2%	+$50.1K	0.04%	131
2026 Q1	$2.56M	Buy	8,757 +333	+4%	+$109K	0.04%	132
2025 Q4	$2.95M	Sell	8,424 -23	-0.3%	-$7.77K	0.04%	132
2025 Q3	$2.73M	Sell	8,447 -350	-4%	-$109K	0.04%	146
2025 Q2	$3.36M	Buy	8,797 +953	+12%	+$383K	0.06%	138
2025 Q1	$3.39M	Sell	7,844 -882	-10%	-$354K	0.07%	130
2024 Q4	$3.22M	Sell	8,726 -4,714	-35%	-$1.97M	0.07%	141
2024 Q3	$5.61M	Buy	13,440 +6,419	+91%	+$3.43M	0.15%	101
2024 Q2	$3.8M	Sell	7,021 -1,902	-21%	-$1.01M	0.05%	148
2024 Q1	$6.75M	Sell	8,923 -7,284	-45%	-$3.62M	0.12%	118
2023 Q4	$7.64M	Buy	+16,207	New	+$7.49M	0.2%	93

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Groupama Asset Management's ELV Position: Q2 2026 in Review

Groupama Asset Management increased its Elevance Health (ELV) stake by 1.5% in Q2 2026, buying an estimated $50.1K and bringing the position to 8,892 shares worth $3.44M. The position accounts for 0.04% of the portfolio, ranked #131.

Groupama Asset Management first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.64M in Q4 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Groupama Asset Management held 8,892 shares of Elevance Health worth $3.44M as of Q2 2026.
Groupama Asset Management bought 135 Elevance Health shares in Q2 2026, an estimated $50.1K.
Elevance Health made up 0.04% of Groupama Asset Management's portfolio in Q2 2026, its #131 holding.
Groupama Asset Management first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
Groupama Asset Management's Elevance Health position peaked at $7.64M in Q4 2023.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.